COLGATE-PALMOLIVE COMPANY Revenue
COLGATE-PALMOLIVE COMPANY (CL) reported Revenue of $5.36 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-07-31
- COLGATE-PALMOLIVE COMPANY revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $5.36B, a 4.91% increase year-over-year.
- COLGATE-PALMOLIVE COMPANY revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $5.32B, a 8.41% increase year-over-year.
- COLGATE-PALMOLIVE COMPANY revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $5.23B, a 5.76% increase year-over-year.
- COLGATE-PALMOLIVE COMPANY revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $5.13B, a 1.95% increase year-over-year.
- COLGATE-PALMOLIVE COMPANY revenue from contract with customer, excluding assessed tax for fiscal 2025 was $20.38B, a 1.40% increase from fiscal 2024.
- COLGATE-PALMOLIVE COMPANY revenue from contract with customer, excluding assessed tax for fiscal 2024 was $20.10B, a 3.31% increase from fiscal 2023.
- COLGATE-PALMOLIVE COMPANY revenue from contract with customer, excluding assessed tax for fiscal 2023 was $19.46B, a 8.29% increase from fiscal 2022.
- COLGATE-PALMOLIVE COMPANY revenue from contract with customer, excluding assessed tax for fiscal 2022 was $17.97B, a 3.13% increase from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.36B 10-Q · filed 2026-07-31 | $10.69B 10-Q · filed 2026-07-31 | $15.91B derived: sum of 3 quarters · filed 2026-07-31 | $21.05B derived: sum of 4 quarters · filed 2026-07-31 |
| 2026-03-31 | $5.32B 10-Q · filed 2026-05-01 | $10.55B derived: sum of 2 quarters · filed 2026-05-01 | $15.69B derived: sum of 3 quarters · filed 2026-05-01 | $20.80B derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-12-31 | $5.23B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $10.36B derived: sum of 2 quarters · filed 2026-02-23 | $15.47B derived: sum of 3 quarters · filed 2026-07-31 | $20.38B 10-K · filed 2026-02-23 |
| 2025-09-30 | $5.13B 10-Q · filed 2025-10-31 | $10.24B derived: sum of 2 quarters · filed 2026-07-31 | $15.15B 10-Q · filed 2025-10-31 | $20.10B derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-06-30 | $5.11B 10-Q · filed 2026-07-31 | $10.02B 10-Q · filed 2026-07-31 | $14.97B derived: sum of 3 quarters · filed 2026-07-31 | $20.00B derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-03-31 | $4.91B 10-Q · filed 2026-05-01 | $9.86B derived: sum of 2 quarters · filed 2026-05-01 | $14.89B derived: sum of 3 quarters · filed 2026-05-01 | $19.95B derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | $4.95B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $9.98B derived: sum of 2 quarters · filed 2026-02-23 | $15.04B derived: sum of 3 quarters · filed 2026-02-23 | $20.10B 10-K · filed 2026-02-23 |
| 2024-09-30 | $5.03B 10-Q · filed 2025-10-31 | $10.09B derived: sum of 2 quarters · filed 2025-10-31 | $15.16B 10-Q · filed 2025-10-31 | $20.11B derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-06-30 | $5.06B 10-Q · filed 2025-08-01 | $10.12B 10-Q · filed 2025-08-01 | $15.07B derived: sum of 3 quarters · filed 2026-02-23 | $19.99B derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-03-31 | $5.07B 10-Q · filed 2025-04-25 | $10.02B derived: sum of 2 quarters · filed 2026-02-23 | $14.93B derived: sum of 3 quarters · filed 2026-02-23 | $19.75B derived: sum of 4 quarters · filed 2026-02-23 |
| 2023-12-31 | $4.95B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $9.87B derived: sum of 2 quarters · filed 2026-02-23 | $14.69B derived: sum of 3 quarters · filed 2026-02-23 | $19.46B 10-K · filed 2026-02-23 |
| 2023-09-30 | $4.92B 10-Q · filed 2024-10-25 | $9.74B derived: sum of 2 quarters · filed 2024-10-25 | $14.51B 10-Q · filed 2024-10-25 | $19.14B derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-06-30 | $4.82B 10-Q · filed 2024-07-26 | $9.59B 10-Q · filed 2024-07-26 | $14.22B derived: sum of 3 quarters · filed 2025-02-13 | $18.68B derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-03-31 | $4.77B 10-Q · filed 2024-04-26 | $9.40B derived: sum of 2 quarters · filed 2025-02-13 | $13.85B derived: sum of 3 quarters · filed 2025-02-13 | $18.34B derived: sum of 4 quarters · filed 2025-02-13 |
| 2022-12-31 | $4.63B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $9.08B derived: sum of 2 quarters · filed 2025-02-13 | $13.57B derived: sum of 3 quarters · filed 2025-02-13 | $17.97B 10-K · filed 2025-02-13 |
| 2022-09-30 | $4.46B 10-Q · filed 2023-10-27 | $8.94B derived: sum of 2 quarters · filed 2023-10-27 | $13.34B 10-Q · filed 2023-10-27 | $17.74B derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-06-30 | $4.48B 10-Q · filed 2023-07-28 | $8.88B 10-Q · filed 2023-07-28 | $13.29B derived: sum of 3 quarters · filed 2024-02-15 | $17.70B derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-03-31 | $4.40B 10-Q · filed 2023-04-28 | $8.80B derived: sum of 2 quarters · filed 2024-02-15 | $13.22B derived: sum of 3 quarters · filed 2024-02-15 | $17.48B derived: sum of 4 quarters · filed 2024-02-15 |
| 2021-12-31 | $4.40B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $8.82B derived: sum of 2 quarters · filed 2024-02-15 | $13.08B derived: sum of 3 quarters · filed 2024-02-15 | $17.42B 10-K · filed 2024-02-15 |
| 2021-09-30 | $4.41B 10-Q · filed 2022-10-28 | $8.67B derived: sum of 2 quarters · filed 2022-10-28 | $13.02B 10-Q · filed 2022-10-28 | $17.34B derived: sum of 4 quarters · filed 2022-10-28 |
| 2021-06-30 | $4.26B 10-Q · filed 2022-07-29 | $8.60B 10-Q · filed 2022-07-29 | $12.93B derived: sum of 3 quarters · filed 2022-07-29 | $17.08B derived: sum of 4 quarters · filed 2022-07-29 |
| 2021-03-31 | $4.34B 10-Q · filed 2022-04-29 | $8.67B derived: sum of 2 quarters · filed 2022-04-29 | $12.82B derived: sum of 3 quarters · filed 2022-04-29 | $16.72B derived: sum of 4 quarters · filed 2022-04-29 |
| 2020-12-31 | $4.32B 10-K · filed 2021-02-18 | $8.48B derived: sum of 2 quarters · filed 2021-10-29 | $12.37B derived: sum of 3 quarters · filed 2021-10-29 | $16.47B 10-K · filed 2023-02-16 |
| 2020-09-30 | $4.15B 10-Q · filed 2021-10-29 | $8.05B derived: sum of 2 quarters · filed 2021-10-29 | $12.15B 10-Q · filed 2021-10-29 | $16.16B derived: sum of 4 quarters · filed 2021-10-29 |
| 2020-06-30 | $3.90B 10-Q · filed 2021-07-30 | $7.99B 10-Q · filed 2021-07-30 | $12.01B derived: sum of 3 quarters · filed 2021-07-30 | $15.94B derived: sum of 4 quarters · filed 2021-07-30 |
| 2020-03-31 | $4.10B 10-Q · filed 2021-04-30 | $8.11B derived: sum of 2 quarters · filed 2021-04-30 | $12.04B derived: sum of 3 quarters · filed 2021-04-30 | $15.91B derived: sum of 4 quarters · filed 2021-04-30 |
| 2019-12-31 | $4.01B 10-K · filed 2021-02-18 | $7.94B derived: sum of 2 quarters · filed 2021-02-18 | $11.81B derived: sum of 3 quarters · filed 2021-02-18 | $15.69B 10-K · filed 2022-02-17 |
| 2019-09-30 | $3.93B 10-K · filed 2021-02-18 | $7.79B derived: sum of 2 quarters · filed 2021-02-18 | $11.68B 10-Q · filed 2020-10-30 | $15.49B derived: sum of 4 quarters · filed 2021-02-18 |
| 2019-06-30 | $3.87B 10-K · filed 2021-02-18 | $7.75B 10-Q · filed 2020-07-31 | $11.56B derived: sum of 3 quarters · filed 2021-02-18 | $15.41B derived: sum of 4 quarters · filed 2021-02-18 |
| 2019-03-31 | $3.88B 10-K · filed 2021-02-18 | $7.70B derived: sum of 2 quarters · filed 2021-02-18 | $11.54B derived: sum of 3 quarters · filed 2021-02-18 | $15.43B derived: sum of 4 quarters · filed 2021-02-18 |
| 2018-12-31 | $3.81B 10-K · filed 2020-02-21 | $7.66B derived: sum of 2 quarters · filed 2020-02-21 | $11.54B derived: sum of 3 quarters · filed 2020-02-21 | $15.54B 10-K · filed 2021-02-18 |
| 2018-09-30 | $3.85B 10-K · filed 2020-02-21 | $7.73B derived: sum of 2 quarters · filed 2020-02-21 | $11.73B 10-Q · filed 2019-11-01 | $15.63B derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-06-30 | $3.89B 10-K · filed 2020-02-21 | $7.89B 10-Q · filed 2019-07-26 | $11.78B derived: sum of 3 quarters · filed 2020-02-21 | $15.75B derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-03-31 | $4.00B 10-K · filed 2020-02-21 | $7.89B derived: sum of 2 quarters · filed 2020-02-21 | $11.87B derived: sum of 3 quarters · filed 2020-02-21 | $15.69B derived: sum of 4 quarters · filed 2020-02-21 |
| 2017-12-31 | $3.89B 10-K · filed 2019-02-21 | $7.87B derived: sum of 2 quarters · filed 2019-02-21 | $11.69B derived: sum of 3 quarters · filed 2019-02-21 | $15.45B 10-K · filed 2020-02-21 |
| 2017-09-30 | $3.97B 10-K · filed 2019-02-21 | $7.80B derived: sum of 2 quarters · filed 2019-02-21 | $11.56B 10-Q · filed 2018-10-26 | |
| 2017-06-30 | $3.83B 10-K · filed 2019-02-21 | $7.59B 10-Q · filed 2018-07-27 | ||
| 2017-03-31 | $3.76B 10-K · filed 2019-02-21 | |||
| 2016-12-31 | $15.20B 10-K · filed 2019-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kenvue Inc. (KVUE) | United States | $33.844B | 22.14 |
| e.l.f. Beauty, Inc. (ELF) | United States | $5.934B | |
| INTERPARFUMS INC (IPAR) | United States | $3.707B | 21.36 |
| COTY INC. (COTY) | United States | $2.307B | -3.15 |
| EDGEWELL PERSONAL CARE Co (EPC) | United States | $1.261B | -13.27 |
| SOLESENCE, INC. (SLSN) | United States | $0.058B | -25.13 |
| Axil Brands, Inc. (AXIL) | United States | $0.042B | 17.24 |
| UNITED GUARDIAN INC (UG) | United States | $0.034B | 13.30 |
| Caring Brands, Inc. (CABR) | United States | $0.013B | |
| BONK, INC. (BNKK) | United States | $0.011B | -0.14 |